SimBioSys Gets 3rd FDA OK for AI-Powered Precision Surgery Tool
Latest release introduces industry-leading AI performance, optimized workflow integration, and enhanced surgeon usability to streamline imaging-to-intervention planning SimBioSys®, a clinical AI company leveraging spatial biophysics to drive precision in breast cancer treatment, today announced its third FDA 510(k) clearance for TumorSight Viz. The clearance expands the platform’s ability to convert standard breast MRI into intuitive,…
